Asarina Pharma Company

Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.

Last Funding Date: 2018-09-20
Investors Number: 4
Industry: General Health Care
Last Funding Type: Post-IPO Equity
Headquarters: Solna, Stockholms Lan, Sweden
Total Funding: $24,828,814
Funding Status: IPO
Employee Number: 1-10
Estimated Revenue: Less than $1M
Founded Date: 01-01-2006